Effects of Supplementation in Healthy Russian Population

Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Selected Nutrients Blood Level and Heart Health Risk Factors in Russian Population

The objectives of this exploratory study are to (1) evaluate the effect of the multivitamin multimineral with phytonutrient product vs. placebo on heart health risk factors following twice-daily consumption for eight weeks; (2) To test the safety and tolerability of the multivitamin multimineral with phytonutrient product vs. placebo following twice-daily consumption for eight weeks.

Study Overview

• Status: Completed
• Conditions: Heart Health Markers; General Nutritional Status
• Intervention / Treatment: Dietary supplement: multivitamin multimineral with phytonutrient supplementation

Detailed Description

More and more evidence shows the benefit of fruit and vegetable intake on the maintenance of good health throughout the lift span. Unfortunately, many people in developed and developing societies do not eat a diet with the variety and quantity of fruits and vegetables. Because of this, prevalence of chronic disease increases rapidly in worldwide as well as the burden on the health care system. Therefore, promoting healthy lifestyle and dietary behavior becomes a critical approach in preventing chronic disease development. According to results from the Moscow Behavioural Risk Factor Survey performed from 2000-2001 found that mean fruit and vegetable intake in men and women in Moscow was 190 grams per day, much lower than the World Health Organization's recommended 400 grams per day. This lower than recommended intake would correlate to a lower intake of phytonutrients and antioxidants and may be associated with higher risks for chronic diseases such as cardiovascular disease (CVD) and cancer. In this study, we are particularly interested in understanding whether a multivitamin multimineral with phytonutrient product can improve nutritional status and reduce heart health risk factors in Russian population with low fruit and vegetable intake. This study is conducted in Russia Institute of Nutrition (ION) clinic, which has 200 beds and outpatients department.

• Study Type: Interventional
• Enrollment (Actual): 120
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Russian Federation
  • Moscow, Russian Federation
    • Russian Institute of Nutrition

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 40 years to 70 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Generally healthy men and women aged from 40 to 70 years of age preferable smokers and who regularly consumes alcohol, and consuming fewer than 12 items found on the Recommended Foods Checklist (see below) per week.
• Individual should be judged to be in good general health on the basis of an interview and abbreviated physical exam.
• Individual understands the procedures and agrees to participate in the study.
• Individual is able and willing to provide written informed consent and confidentiality agreement.

Exclusion Criteria:

• Use of dietary supplements within one week of Day 1. Supplements include any vitamins, minerals, and herbal products, including herbal drinks.
• Presence of cardiovascular disease, hypercholesterolemia, cancer, diabetes mellitus, or any other chronic health condition identified from the findings of the interview.
• Currently treated for uncontrolled hypertension or blood pressure greater > 140 mm Hg systolic or > 90 mm Hg diastolic during seated, resting measurement on two consecutive occasions during visit 1.
• Therapeutic uses of coumadin, aspirin, or other medications that influence hemostasis within four weeks of Day 1.
• Participation in another clinical trial within 30 days of enrollment into the study.
• History or current abuse of drugs or alcohol, or intake > 4 alcoholic beverages per day.
• Known hypersensitivity to study product or any ingredient in study product.
• A change in hormone therapy, including oral contraceptives, within 4 weeks prior to screening, or unwilling to maintain current hormone therapy/oral contraceptive use throughout the course of the study.
• Pregnant or lactating women, or women of child-bearing potential unwilling to use a medically approved form of birth control.
• Any condition that the Principal Investigator believes may put the subject at undue risk.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Active; Active is a multivitamin multimineral with phytonutrient product.	Dietary supplement: multivitamin multimineral with phytonutrient supplementation; The multivitamin multimineral with phytonutrient product consists of four tablets per dose, two "Vitamin" tablets, a "Mineral" tablet, and a "Phytonutrient" tablet. The placebo for this trial will be formulated to match the shape and color of all multivitamin multimineral with phytonutrient product tablets, e.g., a Vitamin Placebo, a Mineral Placebo and a Phytonutrient Placebo.; Other Names: Active is Nutrilite Double X
Placebo Comparator: Placebo; Placebo is a sugar pill.	Dietary supplement: multivitamin multimineral with phytonutrient supplementation; The multivitamin multimineral with phytonutrient product consists of four tablets per dose, two "Vitamin" tablets, a "Mineral" tablet, and a "Phytonutrient" tablet. The placebo for this trial will be formulated to match the shape and color of all multivitamin multimineral with phytonutrient product tablets, e.g., a Vitamin Placebo, a Mineral Placebo and a Phytonutrient Placebo.; Other Names: Active is Nutrilite Double X

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Change of heart risk factors by measuring homocysteine, C reactive protein (CRP), oxidized low-density lipoprotein (Ox-LDL) and lipid profile at baseline and Day 56	Baseline, Day 56
Change of nutrient status by measuring b-carotene, a- and r-tocopherol, vitamin C, folic acid, B6, B12, zinc, selenium, polyphenols at baseline, Day 28 and Day 56	Baseline, Day 28 and Day 56

Secondary Outcome Measures

Outcome Measure	Time Frame
Change of potential heart health risk factors by measuring gamma-glutamyl transferase (GGT) and uric acid	Baseline and Day 56

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change of anthropomorphic evaluation markers by measuring height, weight, body mass index (BMI, kg/m2), and waist-to-hip ratio at baseline and Day 56		Baseline and Day 56
Evaluation of general health status, lifestyle and dietary behavior	dietary questionnaire was used.	Baseline

Collaborators and Investigators

• Sponsor: Access Business Group
• Collaborators: Russian Institute of Nutrition
• Investigators: Principal Investigator: Vasily A Isakov, M.D., Ph.D., Russian Institute of Nutrition

Study record dates

Study Major Dates

• Study Start: October 1, 2010
• Primary Completion (Actual): July 1, 2011
• Study Completion (Actual): September 1, 2013

Study Registration Dates

• First Submitted: December 19, 2013
• First Submitted That Met QC Criteria: August 21, 2014
• First Posted (Estimate): August 25, 2014

Study Record Updates

• Last Update Posted (Estimate): August 25, 2014
• Last Update Submitted That Met QC Criteria: August 21, 2014
• Last Verified: August 1, 2014

More Information

Terms related to this study

• Keywords: heart health; general well-being
• Other Study ID Numbers: Amway-2010-RU1